Reference
Guo J, et al. Capture-based ultra-deep sequencing in plasma ctDNA reveals the resistance mechanism of ALK inhibitors in a patient with advanced ALK-positive NSCLC. Cancer Biology and Therapy 19: 359-363, No. 5, 4 May 2018. Available from: URL: http://doi.org/10.1080/15384047.2018.1433496 - China
Rights and permissions
About this article
Cite this article
Ceritinib/crizotinib/lorlatinib. Reactions Weekly 1702, 73 (2018). https://doi.org/10.1007/s40278-018-46183-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-46183-1